A review on corona virus disease 2019 (COVID-19) : current progress, clinical features and bioanalytical diagnostic methods
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature..
A new epidemic of acute respiratory viral pneumonia was discovered in central China at the end of 2019. The disease was given the name coronavirus disease 2019 (COVID-19), and the virus that caused this disease was known as severe acute respiratory syndrome coronavirus (SARS-CoV-2). So far, diagnostic methods have been focused on (a) human antibody detection, (b) viral antigen detection and (c) viral gene detection, the latter using RT-PCR being the most accurate approach. In this paper, we present a summary of the COVID-19 pandemic, clinical features and epidemiology and pathogenesis. Also, we focus on the recent advances in bioanalytical diagnostic methods based on various techniques for SARS-CoV-2 sensing that have recently been published (2020-2021). Furthermore, we present the mechanisms, advantages and disadvantages of the most common biosensors for COVID-19 detection, which include optical, electrochemical and piezoelectric biosensors as well as wearable and smart nanobiosensors, immunosensors, aptasensors and genosensors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:189 |
---|---|
Enthalten in: |
Mikrochimica acta - 189(2022), 3 vom: 14. Feb., Seite 103 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mollarasouli, Fariba [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bioanalytical methods |
---|
Anmerkungen: |
Date Completed 21.02.2022 Date Revised 16.07.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00604-022-05167-y |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336892705 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336892705 | ||
003 | DE-627 | ||
005 | 20231225233157.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00604-022-05167-y |2 doi | |
028 | 5 | 2 | |a pubmed24n1122.xml |
035 | |a (DE-627)NLM336892705 | ||
035 | |a (NLM)35157153 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mollarasouli, Fariba |e verfasserin |4 aut | |
245 | 1 | 2 | |a A review on corona virus disease 2019 (COVID-19) |b current progress, clinical features and bioanalytical diagnostic methods |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.02.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature. | ||
520 | |a A new epidemic of acute respiratory viral pneumonia was discovered in central China at the end of 2019. The disease was given the name coronavirus disease 2019 (COVID-19), and the virus that caused this disease was known as severe acute respiratory syndrome coronavirus (SARS-CoV-2). So far, diagnostic methods have been focused on (a) human antibody detection, (b) viral antigen detection and (c) viral gene detection, the latter using RT-PCR being the most accurate approach. In this paper, we present a summary of the COVID-19 pandemic, clinical features and epidemiology and pathogenesis. Also, we focus on the recent advances in bioanalytical diagnostic methods based on various techniques for SARS-CoV-2 sensing that have recently been published (2020-2021). Furthermore, we present the mechanisms, advantages and disadvantages of the most common biosensors for COVID-19 detection, which include optical, electrochemical and piezoelectric biosensors as well as wearable and smart nanobiosensors, immunosensors, aptasensors and genosensors | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Bioanalytical methods | |
650 | 4 | |a Biosensors | |
650 | 4 | |a COVID-19 pandemic | |
650 | 4 | |a Coronaviruses | |
650 | 4 | |a Diagnosis | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Zare-Shehneh, Nader |e verfasserin |4 aut | |
700 | 1 | |a Ghaedi, Mehrorang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mikrochimica acta |d 1994 |g 189(2022), 3 vom: 14. Feb., Seite 103 |w (DE-627)NLM000043036 |x 1436-5073 |7 nnns |
773 | 1 | 8 | |g volume:189 |g year:2022 |g number:3 |g day:14 |g month:02 |g pages:103 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00604-022-05167-y |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 189 |j 2022 |e 3 |b 14 |c 02 |h 103 |